302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma
Publication
, Conference
Beasley, G; Farrow, N; Landa, K; Seilm, MA; Jung, S-H; Bigner, D; Kelly, AT; Nair, S; Gromeier, M; Salama, A
Published in: Regular and young investigator award abstracts
November 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Regular and young investigator award abstracts
DOI
Publication Date
November 2020
Publisher
BMJ Publishing Group Ltd
Conference Name
35th Anniversary Annual Meeting (SITC 2020)
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Beasley, G., Farrow, N., Landa, K., Seilm, M. A., Jung, S.-H., Bigner, D., … Salama, A. (2020). 302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma. In Regular and young investigator award abstracts. BMJ Publishing Group Ltd. https://doi.org/10.1136/jitc-2020-sitc2020.0302
Beasley, Georgia, Nellie Farrow, Karenia Landa, Maria Angelica Seilm, Sin-Ho Jung, Darell Bigner, Andrea True Kelly, Smita Nair, Matthias Gromeier, and April Salama. “302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma.” In Regular and Young Investigator Award Abstracts. BMJ Publishing Group Ltd, 2020. https://doi.org/10.1136/jitc-2020-sitc2020.0302.
Beasley G, Farrow N, Landa K, Seilm MA, Jung S-H, Bigner D, et al. 302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma. In: Regular and young investigator award abstracts. BMJ Publishing Group Ltd; 2020.
Beasley, Georgia, et al. “302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma.” Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, 2020. Crossref, doi:10.1136/jitc-2020-sitc2020.0302.
Beasley G, Farrow N, Landa K, Seilm MA, Jung S-H, Bigner D, Kelly AT, Nair S, Gromeier M, Salama A. 302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma. Regular and young investigator award abstracts. BMJ Publishing Group Ltd; 2020.
Published In
Regular and young investigator award abstracts
DOI
Publication Date
November 2020
Publisher
BMJ Publishing Group Ltd
Conference Name
35th Anniversary Annual Meeting (SITC 2020)
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology